Skip to main content
. 2022 Jun 8;3(7):100349. doi: 10.1016/j.jtocrr.2022.100349

Figure 2.

Figure 2

Pathologic images of PD-L1 expression in samples from a representative patient. (A) The primary tumor revealed high PD-L1 expression (original magnification: 200×). (B) The tumor cells in lymphovascular spaces (arrow) did not express PD-L1 (original magnification: 200×). PD-L1, programmed death-ligand 1; TPS, tumor proportion score.